GB0712524D0 - Novel schizophrenia associated genes - Google Patents

Novel schizophrenia associated genes

Info

Publication number
GB0712524D0
GB0712524D0 GBGB0712524.8A GB0712524A GB0712524D0 GB 0712524 D0 GB0712524 D0 GB 0712524D0 GB 0712524 A GB0712524 A GB 0712524A GB 0712524 D0 GB0712524 D0 GB 0712524D0
Authority
GB
United Kingdom
Prior art keywords
associated genes
schizophrenia associated
novel
novel schizophrenia
schizophrenia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0712524.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Pharma Corp
Original Assignee
Mitsubishi Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp
Priority to GBGB0712524.8A priority Critical patent/GB0712524D0/en
Publication of GB0712524D0 publication Critical patent/GB0712524D0/en
Priority to PCT/GB2008/002204 priority patent/WO2009001095A2/en
Ceased legal-status Critical Current

Links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to the identification of genes involved and/or associated with schizophrenia and related diseases, as well as particular identified genes and their potential use in therapy/diagnosis of schizophrenia and related diseases.
GBGB0712524.8A 2007-06-28 2007-06-28 Novel schizophrenia associated genes Ceased GB0712524D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0712524.8A GB0712524D0 (en) 2007-06-28 2007-06-28 Novel schizophrenia associated genes
PCT/GB2008/002204 WO2009001095A2 (en) 2007-06-28 2008-06-26 Novel schizophrenia associated genes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0712524.8A GB0712524D0 (en) 2007-06-28 2007-06-28 Novel schizophrenia associated genes

Publications (1)

Publication Number Publication Date
GB0712524D0 true GB0712524D0 (en) 2007-08-08

Family

ID=38420842

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0712524.8A Ceased GB0712524D0 (en) 2007-06-28 2007-06-28 Novel schizophrenia associated genes

Country Status (2)

Country Link
GB (1) GB0712524D0 (en)
WO (1) WO2009001095A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010029171A (en) * 2008-06-25 2010-02-12 Srl Inc Diagnostic method for integration dysfunction syndrome
ES2562684B1 (en) * 2014-08-04 2017-02-06 Consejo Superior De Investigaciones Científicas (Csic) ANTIPSYCHOTIC TREATMENT MONITORING METHOD

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030175741A1 (en) * 2000-03-31 2003-09-18 Susan Cochran Schizophrenia related gene
JP2003038198A (en) * 2001-07-27 2003-02-12 Univ Niigata Method for analyzing nucleic acid specifying gene having expression level changeable with schizophrenia
WO2005020784A2 (en) * 2003-05-23 2005-03-10 Mount Sinai School Of Medicine Of New York University Surrogate cell gene expression signatures for evaluating the physical state of a subject
EP1639090A4 (en) * 2003-06-09 2008-04-16 Univ Michigan Compositions and methods for treating and diagnosing cancer
WO2005123955A2 (en) * 2004-06-09 2005-12-29 Children's Medical Center Corporation Methods and compositions for modifying gene regulation and dna damage in ageing
JP2008538238A (en) * 2005-03-31 2008-10-16 ザ・ボード・オブ・トラスティーズ・オブ・ザ・レランド・スタンフォード・ジュニア・ユニバーシティ Compositions and methods for diagnosing and treating neuropsychiatric disorders
US20070292880A1 (en) * 2006-05-05 2007-12-20 Robert Philibert Compositions and methods for detecting predisposition to a substance use disorder or to a mental illness or syndrome

Also Published As

Publication number Publication date
WO2009001095A2 (en) 2008-12-31
WO2009001095A3 (en) 2009-03-26

Similar Documents

Publication Publication Date Title
MX2011009539A (en) Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof.
IN2012DN02737A (en)
AU2012205878A8 (en) miRNA for treating diseases and conditions associated with neo-angiogenesis
WO2009026657A8 (en) Flavonoid ppar agonists
MX2018009945A (en) Novel compositions and methods for the treatment of immune related diseases.
MY158992A (en) Forms of rifaximin and uses thereof
MX2009008430A (en) Anti-robo4 antibodies and uses therefor.
MX2009006704A (en) New compounds.
ME01032B (en) Forms of rifaximin and uses thereof
SG10201803862UA (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
EA020330B3 (en) Quinazoline compounds
AU2011274619A8 (en) miRNA and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated BRAF pathway
EP2576578A4 (en) Polymorphs of 2'-o-fucosyllactose and producing thereof
DE602006018709D1 (en) ESTERED GEMINITENSIDE COMPOUNDS FOR USE IN GENDER THERAPY
ECSP11011541A (en) ANTAGONISTS OF THE HEDGEHOG TRAJECTORY OF DISTTITUTED FTALAZINA
PH12015501043A1 (en) Novel compounds
TW200700064A (en) Novel compounds
WO2011053901A3 (en) Magnetic nanostructures as theranostic agents
UA107204C2 (en) ANTI-FUNCTIONAL COMPOSITION CONTAINING THE PYTHIUM OLIGANDRUM Fungal Organism
WO2008060945A3 (en) Diagnosis and treatment of breast cancer
MX2013004747A (en) Peripheral blood gene markers for early diagnosis of parkinson's disease.
GB0803912D0 (en) Novel Uses of VEGFxxxb
GB0712524D0 (en) Novel schizophrenia associated genes
GB0508988D0 (en) Organic compounds
NZ609924A (en) Porphyrin treatment of neurodegenerative diseases

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application
AT Applications terminated before publication under section 16(1)